Skip to main content
For COVID-19 vaccine updates, please
review our information guide
and
sign up for Connect
. Continue your routine care with us by scheduling an
in-person appointment
or
Video Visit
.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle menu options
News and Announcements
Patient Care
Toggle menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 71 results
Author
Title
Type
[
Year
]
Filters:
Keyword
is
Humans
[Clear All Filters]
2021
Lima S
,
Longman RS
. 2021.
A Diamond in the Rough: IgA-Seq Signatures Stratify New Onset IBD.
.
Cell Host Microbe. 29(1):10-12.
2020
Lukin DJ
,
Kumar A
,
Hajifathalian K
,
Sharaiha RZ
,
Scherl EJ
,
Longman RS
. 2020.
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
.
Gastroenterology. 159(4):1541-1544.e2.
Yang E
,
Panaccione N
,
Whitmire N
,
Dulai PS
,
Casteele NVande
,
Singh S
,
Boland BS
,
Collins A
,
Sandborn WJ
,
Panaccione R
et al.
. 2020.
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease.
.
Aliment Pharmacol Ther. 51(11):1031-1038.
Dulai PS
,
Battat R
,
Barsky M
,
Nguyen NH
,
Ma C
,
Narula N
,
Mosli M
,
Casteele NVande
,
Boland BS
,
Prokop L
et al.
. 2020.
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors.
.
Am J Gastroenterol. 115(6):885-894.
Castellanos JG
,
Longman RS
. 2020.
Innate lymphoid cells link gut microbes with mucosal T cell immunity.
.
Gut Microbes. 11(2):231-236.
Lukin DJ
. 2020.
Predictors of Perianal Fistula Relapse in Crohn's Disease.
.
Inflamm Bowel Dis. 26(6):932-933.
Panaccione R
,
Danese S
,
Sandborn WJ
,
O'Brien CD
,
Zhou Y
,
Zhang H
,
Adedokun OJ
,
Tikhonov I
,
Targan S
,
Abreu MT
et al.
. 2020.
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
.
Aliment Pharmacol Ther. 52(11-12):1658-1675.
2019
Cohen-Mekelburg S
,
Gold S
,
Schneider Y
,
Dennis M
,
Oromendia C
,
Yeo H
,
Michelassi F
,
Scherl E
,
Steinlauf A
. 2019.
Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease Patients.
.
Dig Dis Sci. 64(1):196-203.
Agrawal M
,
Cohen-Mekelburg S
,
Kayal M
,
Axelrad J
,
Galati J
,
Tricomi B
,
Kamal K
,
Faye AS
,
Abrudescu P
,
Scherl E
et al.
. 2019.
Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors.
.
Aliment Pharmacol Ther. 49(5):564-571.
Lukin DJ
,
Lawlor G
,
Hudesman DP
,
Durbin L
,
Axelrad JE
,
Passi M
,
Cavaliere K
,
Coburn E
,
Loftus M
,
Jen H
et al.
. 2019.
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
.
Inflamm Bowel Dis. 25(4):775-781.
Gogokhia L
,
Buhrke K
,
Bell R
,
Hoffman B
,
D Brown G
,
Hanke-Gogokhia C
,
Ajami NJ
,
Wong MC
,
Ghazaryan A
,
Valentine JF
et al.
. 2019.
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.
.
Cell Host Microbe. 25(2):285-299.e8.
Cohen-Mekelburg S
,
Rosenblatt R
,
Gold S
,
Shen N
,
Fortune B
,
Waljee AK
,
Saini S
,
Scherl E
,
Burakoff R
,
Unruh M
. 2019.
Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse Outcomes.
.
Am J Gastroenterol. 114(2):276-290.
Ma C
,
Battat R
,
Dulai PS
,
Parker CE
,
Sandborn WJ
,
Feagan BG
,
Jairath V
. 2019.
Innovations in Oral Therapies for Inflammatory Bowel Disease.
.
Drugs. 79(12):1321-1335.
Agrawal M
,
Zhang W
,
Lukin D
. 2019.
Intestinal Spirochetosis Resembles Inflammatory Bowel Disease in a Patient With HIV Infection.
.
Clin Gastroenterol Hepatol. 17(6):e60.
Cohen-Mekelburg S
,
Schneider Y
,
Gold S
,
Ghosh G
,
Rosenblatt R
,
Hajifathalian K
,
Scherl E
,
Schnoll-Sussman F
,
Katz P
,
Steinlauf A
. 2019.
Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
.
Dig Dis Sci. 64(8):2273-2279.
Faleck DM
,
Winters A
,
Chablaney S
,
Shashi P
,
Meserve J
,
Weiss A
,
Aniwan S
,
Koliani-Pace JL
,
Kochhar G
,
Boland BS
et al.
. 2019.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
.
Clin Gastroenterol Hepatol. 17(12):2497-2505.e1.
Patel A
,
Namn Y
,
Shah SL
,
Scherl E
,
Wan DW
. 2019.
Takotsubo cardiomyopathy after an upper and lower endoscopy: a case report and review of the literature.
.
J Med Case Rep. 13(1):81.
Qazi T
,
Verma R
,
Hamilton MJ
,
Kaplan ER
,
Redline S
,
Burakoff R
. 2019.
The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
.
Inflamm Bowel Dis. 25(6):1044-1053.
2018
Zhang S
,
Fu J
,
Dogan B
,
Scherl EJ
,
Simpson KW
. 2018.
5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
.
J Antibiot (Tokyo). 71(11):950-961.
Dulai PS
,
Boland BS
,
Singh S
,
Chaudrey K
,
Koliani-Pace JL
,
Kochhar G
,
Parikh MP
,
Shmidt E
,
Hartke J
,
Chilukuri P
et al.
. 2018.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
.
Gastroenterology. 155(3):687-695.e10.
Dogan B
,
Belcher-Timme HFacey
,
Dogan EI
,
Jiang Z-D
,
Dupont HL
,
Snyder N
,
Yang S
,
Chandler B
,
Scherl EJ
,
Simpson KW
. 2018.
Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome.
.
FEMS Microbiol Lett. 365(22)
Kumar A
,
Kim M
,
Lukin DJ
. 2018.
Helicobacter pylori is associated with increased risk of serrated colonic polyps: Analysis of serrated polyp risk factors.
.
Indian J Gastroenterol. 37(3):235-242.
Cohen-Mekelburg S
,
Rosenblatt R
,
Gold S
,
Burakoff R
,
Waljee AK
,
Saini S
,
Schackman BR
,
Scherl E
,
Crawford C
. 2018.
The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients.
.
J Crohns Colitis. 12(9):1030-1035.
Castellanos JG
,
Woo V
,
Viladomiu M
,
Putzel G
,
Lima S
,
Diehl GE
,
Marderstein AR
,
Gandara J
,
Perez AR
,
Withers DR
et al.
. 2018.
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
.
Immunity. 49(6):1077-1089.e5.
Ghosh G
,
Jacob V
,
Wan D
. 2018.
Plasmablastic Lymphoma in a Patient With Crohn's Disease After Extensive Immunosuppressive Therapy.
.
Clin Gastroenterol Hepatol. 16(4):e41-e42.
1
(current)
2
3
next ›
last »